Bristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the ... - MarketWatch (press release)
Asian Scientist MagazineBristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the .
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... - MarketWatch (press release)
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in .
Regeneron: - FierceBiotech
Regeneron:FierceBiotechIts Phase IIb 'MOBILITY' trial showed that the drug, sarilumab, in combination with the standard RA treatment methotrexate, made a 'significant and clinically meaningful improvement' in RA patients' symptoms compared with those who in the study treated .
Infection Risk High in Juvenile Arthritis - MedPage Today
MedPage TodayInfection Risk High in Juvenile ArthritisMedPage TodayNote that among children with JIA, the rate of infection was not increased with methotrexate or tumor necrosis factor inhibitor use.
When the Reasons Are Unreasonable: The Childhood Cancer Drug Shortage - Huffington Post
When the Reasons Are Unreasonable: The Childhood Cancer Drug ShortageHuffington PostSome of you may recall when earlier this year a story hit the news about a nationwide shortage of the lifesaving childhood cancer drug, methotrexate.